Skip to main content
SpringerLink
Log in

In vitro activity of rifaximin againstHelicobacter pylori

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mégraud F, Lamouliatte H Helicobacter pylori and duodenal ulcer. Evidence suggesting causation. Digestive Diseases and Sciences 1992, 37: 769–772.

    Article  PubMed  Google Scholar 

  2. Rauws EAJ, Tytgat G Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 1990, i: 1233–1235.

    Article  Google Scholar 

  3. Warren JR, Marshall B Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, ii: 1273–1275.

    Google Scholar 

  4. Lamouliatte H Traitement des gastrites chroniques associéesCampylobacter pylori. Gastroenterologie Clinique et Biologique 1989, 13: 101B-106B.

    PubMed  Google Scholar 

  5. Glupczynski Y, Burette A Drug therapy forHelicobacter pylori infection: problems and pitfalls. American Journal of Gastroenterology 1990, 85: 96–102.

    Google Scholar 

  6. European Study Group on Antibiotic Susceptibility of Helicobacter pylori: Results of a multicenter European survey in 1991 of metronidazole resistance inHelicobacter pylori. European Journal of Clinical Microbiology and Infectious Diseases 1992, 11: 777–781.

    Google Scholar 

  7. Marchi E, Montecchi L, Venturini AP, Mascellani G, Brufani M Deoxypyrido (1′,2′:1,2) imidazo (5,4-c) rifamycin SV derivatives. A new series of semisynthetic rifamycins with high antibacterial activity and low gastroenteric absorption. Journal of Medical Chemotherapy 1985, 28: 960–963.

    Article  Google Scholar 

  8. Corazza G, Ventrucci M, Strochhi A, Sorge M, Pranzo L, Pezzilli R, Gasbarrini G Treatment of small intestine bacterial overgrowth with rifaximin, a non absorbable rifamycin. Journal of International Medical Research 1988, 16: 312–316.

    PubMed  Google Scholar 

  9. Szybalski W, Bryson V Genetic studies on microbial cross resistance to topic agents: cross resistance ofEscherichia coli to fifteen antibiotics. Journal of Bacteriology 1952, 64: 489–499.

    PubMed  Google Scholar 

  10. Haas CE, Nix DE, Schentag JJ In vitro selection of resistantHelicobacter pylori. Antimicrobial Agents and Chemotherapy 1990, 34: 1637–1641.

    PubMed  Google Scholar 

  11. Lambert T, Mégraud F, Gerbaud G, Courvalin P Susceptibility ofCampylobacter pyloridis to 20 antimicrobial agents. Antimicrobial Agents and Chemotherapy 1986, 30: 510–511.

    PubMed  Google Scholar 

  12. Hardy DJ, Hanson CW, Hensey DM, Beyer JM, Fernandes PB Susceptibility ofCampylobacter pylori to macrolides and fluoroquinolones. Journal of Antimicrobial Chemotherapy 1988, 22: 631–636.

    Google Scholar 

  13. McNulty CAM, Dent JC, Ford GA, Wilkinson SP Inhibitory antimicrobial concentrations againstCampylobacter pylori in gastric mucosa. Journal of Antimicrobial Chemotherapy 1988, 22: 729–738.

    PubMed  Google Scholar 

  14. Grayson ML, Eliopoulos GM, Ferraro MJ, Moellering RJ Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agents. European Journal of Clinical Microbiology and Infectious Diseases 1989, 8: 888–889.

    Article  Google Scholar 

  15. Mégraud F, Boyanova L, Lamouliatte H Activity of lansoprazole againstHelicobacter pylori. Lancet 1991, 337: 1486.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Bactériologie, Hôpital Pellegrin et Université de Bordeaux II, Place Amélie Raba Léon, F-33076, Bordeaux, France

    F. Mégraud, F. Bouffant & C. Camou Juncas

Authors
  1. F. Mégraud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Bouffant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Camou Juncas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mégraud, F., Bouffant, F. & Camou Juncas, C. In vitro activity of rifaximin againstHelicobacter pylori . Eur. J. Clin. Microbiol. Infect. Dis. 13, 184–186 (1994). https://doi.org/10.1007/BF01982198

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01982198

Keywords

Search

Navigation